ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF)"
Episode Synopsis
CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF), joins Stock Day to give details on developing xB3 for treatment of brain cancer and neurodegenerative disease.
OTCQB: BIOAF # biopharmaceutical company developing xB3 # proprietary platform technology # disease-modifying treatments # Alzheimer’s and Huntington’s # blood-brain barrier (BBB) # brain cancers and neurodegenerative diseases # Canada # Glioblastoma # Parkinson’s # treatment of CNS disorders # Vancouver
Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
OTCQB: BIOAF # biopharmaceutical company developing xB3 # proprietary platform technology # disease-modifying treatments # Alzheimer’s and Huntington’s # blood-brain barrier (BBB) # brain cancers and neurodegenerative diseases # Canada # Glioblastoma # Parkinson’s # treatment of CNS disorders # Vancouver
Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
More episodes of the podcast Stock Day Media
Husqvarna | Delta Apparel, Inc.
12/07/2024
Scheid Vineyards Inc. | Royal Road Minerals
11/07/2024
Navidea Biopharmaceuticals, Inc. | Ekinops
10/07/2024
Laredo Oil, Inc. | BlockQuarry Corp.
03/07/2024
DEEPX | EACO Corporation
02/07/2024
In God we trust